Skip to content
StockMarketAgent
Direct answer
KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $736, high $1244, with mid-point at $984.
Stock analysis

KLAC KLA Corporation fair value $984–$1,244

KLAC
By StockMarketAgent.AI team· supervised by
Analizado: 2026-05-08Próxima actualización: 2026-08-08Methodology v2.4Archetype: Mature compounderNASDAQ · Information Technology
View archive
Precio
$1869.19
▼ -884.78 (-47.33%)
Valor razonable
$984
$984–$1244
Calificación
Vender
confidence 84/100
Potencial alcista
-47.3%
upside to fair value
Margen de seguridad
$836.75
buy below · 15%
Capitalización bursátil
$244.2B
P/E fwd 37.7
Respaldo en inglésES
Mostrando la fuente en inglés mientras traducimos
Este informe aún no se ha traducido. Actualice en unos minutos una vez que la cola de traducción se ponga al día.

§1 Resumen ejecutivo

  • Composite fair value $984 with high case $1,244.
  • Implied downside of 47.3% to fair value.
  • Moat 9/10 · confidence 84/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$984
Margin of safety
-89.9%
Confidence
84/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$1,869.19Price
FV $984.41
High $1,243.87

KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Dominant market share in advanced
    Dominant market share in advanced metrology and inspection.
  • High capital intensity of advanced
    High capital intensity of advanced node defect detection.
  • Bull thesis
    Value: Extreme overvaluation relative to normalized cash flows.

§2 Caso bajista

A synchronized downturn in global WFE spending combined with strict export bans on advanced metrology tools to China severely contracts near-term revenue. Elevated R&D requirements for 2nm transitions crush operating leverageLeverageThe proportion of debt in the company's capital structure. Commonly measured as Debt/EBITDA, Debt/Equity, or Net Debt/EBITDA., forcing margins well below mid-cycle averages.

Cómo puede fallar esta tesis

China Export Ban Expansion

· Medium

Complete restriction on all tier-1 process control equipment sales to Chinese foundries, eliminating a high-margin revenue vector.

FV impact
High
Trigger
12-24 months

WFE Cyclical Collapse

· Medium

Prolonged memory and foundry capex freeze delays 2nm and advanced packaging ramps, stalling KLA's growth trajectory.

FV impact
High
Trigger
6-18 months

Margin Compression via R&D

· Low

Defect detection at angstrom levels demands exponentially higher R&D, structurally degrading peak operating margins below 35%.

FV impact
Moderate
Trigger
24-36 months
Señales de alerta temprana a vigilar
MétricaActualUmbral de activación
Consecutive quarters of declining WFE capex forecasts.MonitorDeterioration versus the report thesis
Increased stringency in US Department of Commerce export controls.MonitorDeterioration versus the report thesis
Sequential operating margin degradation below 38%.MonitorDeterioration versus the report thesis
Delay in major foundry 2nm production schedules.MonitorDeterioration versus the report thesis
Deceleration in advanced packaging (CoWoS) capacity expansion.MonitorDeterioration versus the report thesis

§3 Historial financiero

Cuenta de resultados — últimos seis períodos
ConceptoT−0T−1T−2T−3T−4CAGR
Período2021-06-302022-06-302023-06-302024-06-302025-06-30Trend
Ingresos$9.21B$10.50B$9.81B$12.16B+7.2%
Beneficio bruto$5.62B$6.28B$5.88B$7.40B+7.1%
Beneficio operativo$3.65B$3.99B$3.64B$5.01B+8.2%
Beneficio neto$3.32B$3.39B$2.76B$4.06B+5.2%
BPA (diluido)$13.37$21.92$24.15$20.28+11.0%
EBITDA$4.01B$4.50B$3.90B$5.34B+7.4%
I+D$1.11B$1.30B$1.28B$1.36B+5.3%
SG&A$860.0M$986.3M$969.5M$1.03B+4.6%

Puntuaciones de calidad

Piotroski F-score
9 / 9
Compuesto de calidad 0–9
Altman Z-score
14.61
Riesgo de quiebra (>3 seguro)
Beneish M-score
-2.25
Riesgo de manipulación de beneficios
OCF / Beneficio neto
1.01×
>1 indica alta calidad de los beneficios
Umbral de calidad contable
Pass
Umbral ajustado por sector
ROIC
36.2%
Rentabilidad del capital invertido
Sección 3

Numbers analysis

Asignación de capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Suscriptores individuales — desde §411 secciones más

Leer el análisis completo — 11 secciones más.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Informe completo para cada ticker cubierto
24 meses de archivo de calificaciones
Briefings de lista de seguimiento + alertas de cambio de calificación
Exportación PDF + DOCX en cualquier idioma
Comenzar prueba gratuita
Cancela cuando quieras.
FAQ

KLAC — frequently asked questions

  1. Based on our latest analysis, KLAC looks meaningfully overvalued. The current price is $1869 versus a composite fair-value midpoint of $984 (range $736–$1244), which implies roughly 47.3% downside to the midpoint.
Related coverage

Names readers of KLAC also follow

Same archetype: mature-compounder
Same sector: Information Technology